Exploring The Dreamm 5 Platform Trial
Let's dive into the details surrounding The Dreamm 5 Platform Trial.
- Dr. Sagar Lonial (Winship Cancer Institute, Emory University—Atlanta, GA) discusses
- Paul Richardson, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses
- Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, introduces
- Clifton Leaf, Editor-in Chief of Fortune Magazine leads a discussion with Brian Alexander, Dana Farber, Amy McKee, FDA, and ...
- On September 17, 2021, the
In-Depth Information on The Dreamm 5 Platform Trial
Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, talks on the ongoing DREAMM In this video, Natalie Callander, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI, presents some ... The DREAMM
Dr. Ben Saville speaks about how to design an adaptive
That wraps up our extensive overview of The Dreamm 5 Platform Trial.
